Deimed - Company finances
|
EUR
|
2020
From: 2020-11-06
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|
|
Financial data
|
||||||
| Sales revenue | - | 9,403 | 15,751 | 27,107 | 32,571 | 33,660 |
| Profit before tax | -494 | 2,090 | 3,906 | 11,007 | 4,246 | 17,810 |
| Net profit | -494 | 2,009 | 3,712 | 10,457 | 3,999 | 16,741 |
| Equity | -444 | 1,565 | 1,276 | 3,633 | 3,033 | 2,574 |
| Liabilities | - | - | 518 | 827 | 370 | 1,211 |
| Non-current assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Current assets | 5 | 2,101 | 1,794 | 4,460 | 3,403 | 3,785 |
| Total assets | 5 | 2,101 | 1,794 | 4,460 | 3,403 | 3,785 |
|
Taxes paid
|
||||||
| STI taxes | - | - | - | 1,634 | 1,920 | 2,885 |
|
Financial indicators
|
||||||
| Revenue change y/y | - | - | +67.5% | +72.1% | +20.2% | +3.3% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -9880.0% | 95.6% | 206.9% | 234.5% | 117.5% | 442.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | 128.4% | 290.9% | 287.8% | 131.8% | 650.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | 21.4% | 23.6% | 38.6% | 12.3% | 49.7% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | 22.2% | 24.8% | 40.6% | 13.0% | 52.9% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | 0.4 | 0.2 | 0.1 | 0.5 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Deimed - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2023-07-19 | 2023-07-31 | 115.08 |
| 2022-07-01 | 2022-07-31 | 50.95 |
Deimed - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Deimed, MB (company code 305653606) is a Small partnership operating in other human health activities n.e.c. In 2025, the company generated revenue of €33.7K, up 3.3% year on year and 24.2% compared with 2023. Net profit rose sharply to €16.7K in 2025 from €4.0K in 2024 and €10.5K in 2023, lifting the profit margin to 49.7% after 12.3% in 2024 and 38.6% in 2023. The improvement in 2025 reflects a much stronger bottom line despite only modest revenue growth.
The balance sheet remained small. At the end of 2025, total assets were €3.8K, equity €2.6K and liabilities €1.2K. Equity still represented a solid share of the financing structure, with a debt-to-equity ratio of 0.47 and an equity ratio of 68.0%. Asset turnover reached 8.89x, indicating a high level of revenue generated from a relatively small asset base. Revenue per employee was €16.8K and profit per employee €8.4K. ROE and ROA were very high, mainly because they were calculated on a very small equity and asset base.
The balance sheet remained small. At the end of 2025, total assets were €3.8K, equity €2.6K and liabilities €1.2K. Equity still represented a solid share of the financing structure, with a debt-to-equity ratio of 0.47 and an equity ratio of 68.0%. Asset turnover reached 8.89x, indicating a high level of revenue generated from a relatively small asset base. Revenue per employee was €16.8K and profit per employee €8.4K. ROE and ROA were very high, mainly because they were calculated on a very small equity and asset base.